Triglyceride-glucose index is associated with severe obstructive coronary artery disease and atherosclerotic target lesion failure among young adults

Cardiovasc DiabetolPublished Case-control study with prospective cohort follow-up

Main finding · Prevalent EOCADResult — go to the resultAdjusted odds ratio 1.40 95% CI 1.23–1.60

Authors' conclusion

TyG index is positively associated with prevalent EOCAD and incident TLF. TyG index appeared to be a valuable component of future efforts to improve CAD risk stratification and TLF outcome prediction among young adults.

Study context

Population
Young adults aged ≤45 years, 38 hospitals in China, 2017–2020; EOCAD patients 39.6 ± 4.4 years, 95.4% male; controls 39.0 ± 4.4 years, 46.4% male
Participants
1,513 vs 1,513
Comparison
Triglyceride-glucose (TyG) index
  • EOCADn = 1,513
  • Controlsn = 1,513reference
Outcome
Association of TyG index with prevalent EOCAD and incident TLF after successful PCI
Methodological detailsmulticentre, age-matched controls
  • Multicentre
  • Age-matched controls

Main finding

Prevalent EOCAD

Adjusted odds ratio

1.40

95% CI 1.23–1.60

TyG index per SD increase
aOR 1.40 (95% CI 1.23–1.60)

Per SD increase, as printed

As reported in the abstract

Observational data: associations, not effects.

Further findings

OutcomeEstimate
Incident TLF · median 33 month (IQR: 31-34 months)Top TyG index tertilevs Bottom TyG index tertileaHR 2.410 (95% CI 1.07–5.42)
Incident TLF · median 33 month (IQR: 31-34 months)TyG index per SD increaseHR 1.30 (95% CI 1.01–1.73)
Incident target lesion failure (TLF) — Patients with TLF
43 (3.3%)

Diagnostic ability for EOCAD with TyG index added to empirical risk model

Net reclassification improvement 0.10 (95% CI 0.03-0.17)
P = 0.005

AUC to predict TLF: conventional risk factors vs plus TyG index

AUC improved
0.722-0.734, p = 0.04

Original publication

Triglyceride-glucose index is associated with severe obstructive coronary artery disease and atherosclerotic target lesion failure among young adults. Cardiovasc Diabetol. Published 21 October 2023. doi:10.1186/s12933-023-02004-1

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.